Other safety alerts
|
| |
| China: CFDA’s announcement concerning the halt of import of four medicinal products including brain protein hydrolyzate injection |
| |
In Hong Kong, CEREBROLYSIN INJ(HK-29305) is a pharmaceutical product registered by EVER NEURO PHARMA (ASIA) LIMITED. The Department of Health (DH) has contacted EVER NEURO PHARMA (ASIA) LIMITED, and confirmed that the specification of the said product is consistent with the locally registered specification. The other products including Kyushin Pills of Japan Kyushin Pharmaceutical Co. Ltd, bacterial lysates of Bruschettini Laboratories, and cefpodoxime of AurobindoPharma Ltd are not registered pharmaceutical products in Hong Kong.
Please refer to the following Chinese website for details:
http://www.drugoffice.gov.hk/eps/news/../25689.html
Ends/ Saturday, January 23, 2016
Issued at HKT 13:00
|
| |
|
